Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Crit Care Med. 2022 Feb 7;50(6):924–934. doi: 10.1097/CCM.0000000000005470

Table 2.

Clinical Outcomes

Variable Control (n=28) Warming (n=28) Difference (95% CI)
28-day mortality, n (%) 12 (43) 5 (18) −25 ([−48]- [−2])
Delta-SOFA, mean (SD) −1.6 (3.0) −1.8 (2.4) −0.2 ([−1.6] – 1.3)
28-day hospital-free days, median (IQR) 0 (0–11.3) 13.1 (0–16.8) 2.6 (0–11.6)
28-day ventilator-free days, median (IQR) 17.6 (0–24.2) 21.6 (2.6–24.1) 0.1 (−6.1–1.0)
Secondary infection within 30 days, n (%) 9 (32) 8 (29) −4 ([−28] – 20)
 Abdominal 1 (11) 3 (38)
 Bone/soft tissue 1 (11) 0 (0)
 Catheter 1 (11) 1 (13)
 Pneumonia 4 (44) 4 (50)
 Urinary 1 (11) 0 (0)
 Wound 1 (11) 0 (0)